Related by context. Frequent words. (Click for all words.) 75 Clinical Trial Results 75 Drug Eluting Stents 74 Patients Treated 74 Overactive Bladder 72 Drug Eluting Stent 72 Heart Failure Patients 71 Phase III Clinical Trial 71 Receives FDA Clearance 71 Completes Enrollment 71 Low Dose 70 Well Tolerated 70 Coronary Stent 70 Gastric Cancer 70 Stenting 70 Meta Analysis 70 Pivotal Trial 70 Non Invasive 70 Phase III Trial 70 FDA Clears 70 Benign Prostatic Hyperplasia 69 Urinary Incontinence 69 Elderly Patients 69 Carotid 69 Cancer Treatments 69 Acute Myocardial Infarction 69 Cardiac Resynchronization Therapy 69 Autologous 68 Preclinical Data 68 Prostate Cancer Treatment 68 Advanced Prostate Cancer 68 Metastatic Colorectal Cancer 68 Venous Thromboembolism 68 FDA Clearance 68 Prostate Cancer Patients 68 Patient Enrollment 68 Occlusion 68 Cardiovascular Events 68 Drug Candidate 67 Postmenopausal Women 67 Stent System 67 Combination Therapy 67 Metastatic Melanoma 67 Breast Cancer Patients 67 Significantly Reduces 67 Randomized Controlled Trial 67 Microspheres 67 Diabetic Patients 67 Soft Tissue 67 Blood Flow 67 Minimally Invasive 67 Ischemic 67 Bypass Surgery 67 Peripheral Artery Disease 66 Vertebroplasty 66 Regimens 66 Bone Graft 66 Monotherapy 66 Pivotal Phase III 66 Reduces Risk 66 Acute Coronary Syndromes 66 Blood Clots 66 Resection 66 Blood Thinner 65 Study Demonstrates 65 Hormone Therapy 65 Ablation 65 Chronic Heart Failure 65 Atopic Dermatitis 65 Gum Disease 65 Pulmonary Arterial Hypertension 65 Aortic 65 FDA Accepts 65 Chronic Hepatitis C 65 Breast Cancer Treatment 64 Cholesterol Drug 64 Bladder Cancer 64 Allergic Rhinitis 64 TAXUS ® 64 Virtual Colonoscopy 64 FDA Approves 64 J Am Coll 64 Coronary Stent System 64 Esophageal 64 Generic Version 64 Enoxaparin 64 Cancer Therapies 64 Clinical Outcomes 64 Autoimmune Diseases 64 Tolerability 64 k Clearance 64 Peripheral Arterial Disease 63 Ventricular 63 Small Molecule 63 Pivotal Phase 63 Sirolimus 63 Extended Release 63 Targeted Therapy 63 Blood Vessels 63 Anticoagulation 63 Cancer Cells 63 Percutaneous